Humour is great, it can even help to relieve anxiety around worrying issues. Here are our top 10 Coronavirus One Liner Jokes. Be careful though, humour is infectious and these jokes are going viral.
10. I know a great joke about Corona Virus, you probably won't get it though.
9. A man walks into a bar and goes up to the bartender and says "I'll have a Corona please, hold the virus"
8. If I get quarantined for two weeks with my wife and I die. I can assure you it was not the virus that killed me.
7. With all this talk of Corona Virus, the people who make sanitising gel are rubbing their hands together.
6. I went to the chemist today and asked the assistant "what kills the Corona Virus?"
She replied to me "Ammonia Cleaner"
I said "Oh, I am sorry, I thought you worked here"
5. *Breaking News!* – Apparently the first person in Melbourne has died because of the Coronavirus. In his house they found 1000 cans of food, 50 kilos of pasta, 80 kilos of rice, 300 toilet rolls and 50L of hand sanitiser which he had panic purchased from the supermarket and stock piled "just in case".
The whole lot collapsed and buried him.
4. Since everybody has now started washing their hands, the peanuts at the bar have lost their taste.
3. They said that a mask and gloves were enough to go to the supermarket. They lied, everyone else has clothes on.
2. What's the difference between COVID-19 and Romeo and Juliet? One's the coronavirus and the other is a Verona crisis.
I. I ran out of toilet paper and had to start using old newspapers. Times are rough.
AND THERE'S MORE
You know what they're saying about 2020. It went viral faster than anyone thought it would.
What do you call panic-buying of sausage and cheese in Germany? The wurst-kase scenario.
Nail salons, hair salons, waxing center and tanning places are closed. It's about to get ugly out there.
Why don't chefs find coronavirus jokes funny? They're in bad taste.
What should you do if you don't understand a coronavirus joke? Be patient.
The grocery stores in France look like tornadoes hit them. All that's left is de brie.
I'll tell you a coronavirus joke now, but you'll have to wait two weeks to see if you got it.
Finland just closed its borders. You know what that means. No one will be crossing the finish line.
Why didn't the sick guy get the joke? It flu over his head.
What types of jokes are allowed during quarantine? Inside jokes!
What's the best way to avoid touching your face? A glass of wine in each hand.
If coronavirus isn't about beer, why do I keep seeing cases of it?
So many coronavirus jokes out there, it's a pundemic
Did you hear the joke about the germ? Never mind, I don't want to spread it around.
>>>>> NO JOKE >>>
Excerpt: "...the Covid-19 Delta variant is fictitious, dreamt up by maniacal people who feared losing their stranglehold on a compliant citizenry. As society came to terms with a virus no more lethal than the common flu, and citizens eschewed masking and raised legitimate questions about hazardous vaccinations, the World Health Organization contacted its agents within the CDC and international health agencies and urged them to take part in a program aimed at once again scaring the world into frightened compliance. "It was Biden’s CDC Director, Rochelle Walensky, who recommended an illusory solution; fabricating a highly transmissible and potentially more virulent strain to 'scare people into wearing masks and getting vaccinations,' " https://realrawnews.com/2021/07/trump-pledges-to-blow-lid-off-global-plandemic/ [show less]
··
View all 5 replies
N......
My half sister works for a big company that produces tests for the UK. I asked her if she was aware of any test that differentiates between Covid 19 and the Delta variant. And she said no, that it’s just based on observing “symptoms that are more like a cold or hay fever”. I was like “aha!”
L.....
Because the delta variant IS hay fever, hence why it is appearing during the summer when most have problems with hay fever.
Vitamin D does treat liver disease. Way back in December 2009, I wrote about how vitamin D had brought myself and one other family member's liver markers into the normal range. This included a problem with hepatitis—Hepatitis C Cured? By now I have had many tell me that taking vitamin D had cleared up their liver. The commercial that we are constantly bombarded with on TV about you don't have to have Hep C anymore is a drug that is most likely just a vitamin D mimic or analogue (A manmade molecule or compound that is similar to the natural molecule.).
The Vitamin D Council, Dr. Cannell, has ranted on about how vitamin A is destructive to the level of vitamin D. Strictly speaking this is true. He even had a disagreement with the Weston Price Foundation about the need for vitamin A. Cannell's contention was that vitamin A build-up in the liver was the cause of chronic liver disease. The truth, vitamin D and vitamin A form a dimer in some of the most important functions in the body. If you are getting enough vitamin D, your liver clears of vitamin A. The important functions that I can think of immediately are cellular differentiation and stimulating the immune system, specifically the start of increasing antimicrobial peptides that are your body's natural pathogen killer cells. After several months of supplementing with vitamin D, I had to also supplement with vitamin A, retinol palmitate, for the effectiveness of vitamin D. Until trials are run with the combination of vitamin D and vitamin A, there will continue to be confusion over the effectiveness of fat-soluble vitamins. Our forebears were absolutely correct in their supplementation with cod liver oil.
It is the combination of vitamin D and vitamin A that is critical to your health. Our fathers of medicine have long ranted about the dangers of fat-soluble vitamins. The primary reason for this is not a lack of understanding, but the need to sell you pharmaceutical analogues. Eat large amounts of beta carotene as that is not dangerous was the mantra. The truth is that large amounts of beta carotene can be very dangerous to the lungs. The liver does not convert beta carotene until you are already deficient in vitamin A. The manufacturers of vitamins have reduced the amount of beta carotene that was in multivitamins.
Now with nutraceuticals that are available, we can have our cake and eat it too. Dr. P. R. Raghavan has created the nutraceutical Metadichol. This works to bring the body to homeostasis. It works along many pathways included genetic expression and control of the molecular receptors. What is Metadichol and why is it so effective in treating disease and healing wounds? Metadichol is made of policosanol that is commonly found on all plants. The problem in modern nutrition is that we take away the part of the plant where the concentration of the policosanol is the highest. The advantage of Metadichol is it is made by making a small particle emulsion. We did some of this on our own when we used to chew the husk from food. Now, we have the opportunity to assure that we are getting enough policosanol for health. Taking policosanol as a supplement is not the same as the small particle emulsion. Dr. Raghavan has published over ten papers on the matter and is going around the world to lecture and help other researchers understand the importance of the small particle emulsion of policosanol. Metadichol is very important in how it puts the vitamin D receptor into the state that is required for health. The vitamin D receptor is like the conductor of an orchestra in the smooth harmonies of all receptors. Here is a recently published article on how Metadichol is significant for liver disease.
"A Multi Gene Targeting Approach to Treating Liver Diseases with Metadichol®"
Abstract
Liver diseases are becoming a major health concern. In the developing countries it is due to microbial infection. In the rest of the developed world it is due to alcohol abuse. Chronic liver disease and cirrhosis are a significant health concern in western countries. It is the fifth most common cause of death, after heart disease, cancer, stroke, and chest disease. The liver is capable of regeneration, but it can be overwhelmed leading to liver diseases like cirrhosis and hepatocellular cancer (HCC).
Vitamin D levels are low in most patients with liver diseases, and this suggests possible therapeutic benefits with use of vitamin D or its analogues. Vitamin D, through the vitamin D nuclear receptor (VDR) plays a crucial role in mineral ion homeostasis. The liver has a central role in vitamin D synthesis and there is a need for an agent that will not lead to hypercalcemia. Metadichol, a nano-emulsion of long-chain alcohols derived from food, is an inverse agonist of Vitamin D can fill this void.
In Diabetic rat studies, it inhibits TNF alpha, ICAM1 (intracellular adhesion molecule), CCL2 (chemokine C-C motif) also referred to as monocyte chemoattractant protein 1 (MCP1). All these cytokines, chemokines are known to have important role in liver diseases. We show that Metadichol indeed does work in liver disease patients by normalizing essential liver enzymes ALT, AST and ALP, and GGT. This approach is an example where Metadichol targets multiple genes and via multiple pathways to bring about homeostasis of the liver and is a useful, safe, nontoxic product in treating liver diseases and alleviating a global threat.
Please note that I have not been writing due to the long-term illness and recent death of my brother from agent orange exposure during his thirty months at war in Vietnam. The mutation of his genes from the dioxin exposure prevented his physiology from reacting normally to modern medicine and nutrition. Interestingly, the doctors and researchers in my family have agreed to this. War and the aftermath is hell.
Clotho is one of the three Greek fates that are responsible for the thread of life in Greek mythology. Clotho is known as the spinner of the thread while the others draw out and cut. In our understanding of physiology, we have named the gene responsible for reduced chronic disease—Klotho. The up regulation of klotho appears to significantly reduce chronic disease. A few to consider are cancer, diabetes, rheumatoid arthritis, and coronary artery disease. Have we stumbled unto the gene that is responsible for the fountain of youth?
The klotho gene appears to be regulated by constituents of the vitamin D family, especially the vitamin D nuclear receptor (VDR). In the past, DR. P. R. Raghavan has shown that Metadichol acts to regulate VDR. In the paper, "Metadichol a Novel Agonist of the Anti-aging Klotho Gene in Cancer Cell Lines," it is shown how Metadichol up regulates klotho in pancreatic cancer cells by as much as ten-fold against controls. Here is the link to the paper: METADIHCOL-KLOTHO
Here is the paper abstract:
Abstract
Klotho is an anti-aging protein that is mostly secreted by the kidneys, the brain, and the thyroid. It plays a significant role in regulating kidney function and vascular health. Klotho gene is named after "the Spinner" (Clotho from Greek mythology), the goddess who spins the thread of life. Klotho is a transmembrane protein known to be a co-receptor for Fibroblast Growth Factor-23. Klotho gene is expressed in a variety of tissues changes in the levels are associated with many diseases. Klotho is a tumor suppressor in breast cancer and its expression is reduced in human pancreatic adenocarcinoma, and treatment with klotho inhibits the growth of pancreatic cancer cells in vitro and in vivo.
Growing evidence suggests that an increase in Klotho (KL) expression may be beneficial for age-related diseases such as arteriosclerosis and diabetes. It remains a challenge today to induce Klotho expression. Herein we show that treating pancreatic cancer cells PANC1, MIAPACA and COLO-205 with Metadichol® a novel food-based lipid emulsion of long chain alcohols at picogram/ml, concentration led to a 4 to10 fold increase in Klotho expression as seen quantitative RT-PCR. These results suggest the use of Metadichol® given its constituents that are present in foods we consume every day is a novel therapeutic intervention for pancreatic cancer and other diseases.
The importance of vitamin D and common food compounds like the long chain alcohol lipids that comprise Metadichol is once again shown. We did not have to spend years in Florida looking for the fountain of youth. I bet Ponce de Leon would be very jealous. –Pandemic Survivor.
You might remember the incident last year when a Google update essentially shadow banned all health websites not owned by billion dollar corporations.
Without anyone noticing, they stopped showing the results of hundreds, if not thousands, of non-institutional health websites — some of them quite reputable and well-established.
In a nutshell, Google has stopped showing you the information that you want to see. Instead, Google is taking it on themselves to decide what health information you are allowed to see.
This censorship has come in the form of Google deliberately placing a systematic penalty on the vast majority of health sites to make sure that they don't show up on the first page of search results. This includes SelfHacked, our flagship website where we have been providing information on natural, science-based health topics for many years.
If you haven't already heard about this, you're probably thinking that I sound crazy, but if you don't believe me, just look up the terms "natural cancer treatments" in Google and Bing. Check out the difference in the types of results that you see on the first page.
Or you can try to do a Google search for any other health information, and look at which websites show up on the first page – websites owned by big corporations, usually aligned or partnered with pharmaceutical companies. Google (Alphabet) itself has a pharmaceutical division.
The Problem with Google's "Thought Policing"
Some people might say that Google is a private company and they can run their search engine however they want. That may be true, except for the lack of transparency from Google about what they are doing.
Google has been pretending like there's an algorithm that is fair and anyone can rank so long as their content is high quality. This used to be true, but not anymore.
Most people don't use Google thinking that they are taking sides in a debate or suppressing thousands of health websites because they don't align with Google's ideology — they see it as a tool or medium to find information.
Users don't see it as Google's job to tell you what you should be looking for, or what you should or shouldn't be allowed to know about. Searchers want Google to give them the information they are seeking.
Google is being dishonest by pretending to be an unbiased medium — but in actuality, they are pushing their agenda and ideology onto people.
Now, if people are "cheating" and using "black-hat" SEO tricks to inflate their rankings, then I completely understand why those sites should be penalized. Butwe followed all of the rules, and we're still being censored.
All of our content is backed by science, written by scientists and reviewed by medical professionals. Despite this, we were penalized and have not recovered despite our best efforts to comply with Google's rule book. There hasn't been any other independent health website that has recovered either.
New Direction For SelfHacked
Unfortunately, Google's actions have caused a ripple effect for many companies. As you can imagine, curating the best health content backed by scientific references throughout each article takes a lot of effort from an entire team of people.
I've heard from many other independent health influencers and websites that they are struggling because of the censorship.
The vast majority of traffic to health websites run through Google (90%). Without that source of traffic, there is no way to break even on costs.
But despite the nefarious efforts to silence independent health websites, we can see that people still need the content that SelfHacked provides.
Every day we still get messages from readers telling us about how helpful an article has been and people continue to reach out asking us to write new articles on various health-related topics.
That's why we've made a commitment to make sure that SelfHacked continues to be available as a resource, but something has to change.
The only way we can be an independent publisher that is faithful to the science and not reliant on Google's agenda is to implement a premium subscription service. We've put this off for as long as possible, but it's clear now that now this is the best way to continue to serve our customers in this age of censorship.
Very soon, SelfHacked articles will only be available to people who have signed up as members.
But, we always want to provide the most valuable and helpful products to our community and that's why we're including access to SelfHacked with our genetic and lab test analysis tool, SelfDecode, atno extra cost.
Subscribers will have access to:
ALL SelfHacked articles (ad-free!) – Read from over 1500 science-based health articles that go in-depth on the benefits of natural supplement and lifestyle health changes.
SelfDecode Personalized Genetics Blog – 400 personalized genetics articles help you get to the root cause of your health issue using your unique DNA.
Personalized DNA Wellness Reports – in depth genetic reports on topics like gut health, thyroid, mood, longevity, sleep that provide you with recommendations specific for your body, so that you can solve any health problem you're experiencing.
Lab Test Analyzertool – Upload your lab results and discover how you can get your levels to the optimal range. We analyze ~1000 labs. We will add any lab that we don't have!
and so much more!
You can get all of these with one single SelfDecode subscription, for ONLY $8/month (billed annually).
We would've been charging this for each individual subscription, but I told my team that I wanted to give the most value to our community at the lowest cost.
The combination of SelfDecode with SelfHacked and LabTestAnalyzer is the best resource for improving and optimizing your health.
Health practitioners are also huge fans of these tools and they've been giving us great reviews. If you're a health practitioner and want to learn more about all the tools we have added recently, schedule your free demo tour here.
This change is coming in less than 72 HOURS.
If you're one of the first 50 people to join before we launch the change, we will write an articleabout any health topic that you want and publish it on SelfHacked or SelfDecode (if it's a genetic topic). Just forward your receipt after signing up to support@selfhacked.com with your topic and we'll pass it along to our science writers!
Sign up for SelfDecode today to lock in unlimited access to SelfHacked and get access to all the tools you need to fully optimize your health. You can get everything that we've created over the past 6 years, for $8/month (billed annually)!
Let's show Google that we will be in control of the health information we consume, despite their efforts to silence us.
When you support SelfDecode, you aren't just getting access to the information you need to improve your own health, you are helping to ensure that the entire world will continue to have access to natural, holistic and science-based health information for many years to come.
?Monoclonal antibodies help Americans most at risk for COVID-19
The therapy can be lifesaving, especially in the early stages of an infection, and it's becoming easier to access.
First came the sniffles. Guadalupe Ramirez dismissed them as nothing to be worried about. She popped a pill and forgot about them.
Next came the searing back pain. She dismissed that, too. She'd had rheumatoid and osteoarthritis for more than a decade and recovered from a brain tumor in 2018. She was used to pain.
But she called her doctor anyway to report the flare-up and its unusual location along her spine.
Ramirez said she thought the doctor was being silly when she suggested getting a coronavirus test. Ramirez had barely left the house in months. But the test came back positive.
Her doctor became insistent: Get monoclonal antibodies and get them fast.
Although it was nearly an hour's drive to downtown Houston from her home near Clear Lake, Texas, two days later, on a Wednesday in January, Ramirez made the trip.
It may have saved her life.
"By Saturday, I wanted to go jogging," said the 55-year-old former probation officer. "I woke up like somebody gave me a happy pill."
Monoclonal antibodies, which provide extra immune soldiers to help the body fight off COVID-19, are aimed at people such as Ramirez, who are at high risk for serious disease because they will probably have trouble fighting off the virus on their own.
President Donald Trump credited them for quickly restoring him to health when he caught COVID-19 last fall. He called on the government to provide free doses to any high-risk American who needed one.
As of Wednesday, the government had bought nearly 1 million doses of monoclonals from the two companies that have authorized products, Regeneron and Eli Lilly,and has made them available to 5,800 sites across the country.
Many hospital systems, particularly those in large urban areas, have adopted the drugs. Forty-three percentof the federally funded doses have been used in patients, according to the Department of Health and Human Services. The remaining doses sit on pharmacy shelves.
Last month, the Biden administration announced a $150 million plan to improve access to the drugs, particularly among vulnerable people.
Delivering monoclonal antibodies has been challenging, requiring an extended infusion and an hour of observation, as well as a dedicated space, away from other people who might catch the disease. Many hospitals struggled to set up such infusion centers when they were needed most, in early January at the height of the U.S. pandemic.
Monday, Regeneron released trial results showing that its antibodies, called REGEN-COV, can be delivered via four near-simultaneous shots, rather than an extended infusion, which should make the drug easier to deliver.
Dr. Daniel Griffin, an infectious disease specialist with ProHEALTH
It's one of those therapies where you don't need a statistician to tell you it makes a difference. You're seeing a patient 36 hours later, saying 'I feel great!'
The drugs, which are safe for most people, have become more accessible, doctors said, and they work well, when a patient or doctor asks for them early enough in the disease course.
"We're finally getting them into people," said Dr. Daniel Griffin, an infectious disease specialist with New York-based health care provider ProHEALTH.
Getting monoclonals into arms
Several changes have happened since early this year to get more monoclonals into patients, Griffin and others said.
Most importantly, he said, research has shown that the drugs are effective, helping 80% to 90% of patients who receive them to avoid hospitalization or worse.
"It's one of those therapies where you don't need a statistician to tell you it makes a difference," Griffin said. "You're seeing a patient 36 hours later, saying, 'I feel great!'"
The Food and Drug Administration allowed health care centers to set up monoclonal antibody infusion centers, so the drugs don't have to be administered in a busy emergency room.
"These people are at the height of their infectiousness," Griffin said. "You do not want to sit them in a room, much like an emergency room, with people who are most vulnerable."
Guadalupe Ramirez received monoclonal antibodies from Regeneron to prevent her COVID-19 from getting worse.HANDOUT
The FDA also allowed in-home infusions, in which trained personnel come to the patient's home to deliver the drug.
"So now we have multiple avenues of access all allowing you to get therapy within 24 hours of thinking this is something required," said Griffin, whose health care system provides infusions in a tent next to an emergency room.
The federal government continues to increase the type of sites where the drugs are available, including urgent care facilities, doctor's offices, nursing homes, assisted living facilities, health centers, correctional facilities and dialysis centers, HHS spokesperson Gretchen Michael said in an email.
Griffin said more research is needed to know whether it makes sense to provide monoclonal antibodies to those with less than the highest risk for severe COVID-19, or whether they can prevent symptoms of "long COVID," which can linger for months after an infection.
According to the FDA, monoclonal antibodies are recommended to be used in adults who are over 65, immunocompromised, have a body-mass index of 35 or above, chronic kidney disease, diabetes requiring medication or coronary artery disease.
Dr. Howard Huang, medical director of the lung transplant program at Houston Methodist Hospital
If you're combatting a virus and trying to inhibit its multiplication, we're talking about every hour, every day you wait that makes a big, big difference.
"Everybody in our medical center who (tests positive for the coronavirus) is evaluated for these criteria and immediately contacted," said Dr. William Schaffner, an infectious disease specialist at the Vanderbilt University School of Medicine in Nashville, Tennessee. "We are assiduous about that."
Vanderbilt has treated more than 1,400 people with monoclonal antibodies since late last year and cut its hospitalization rate by more than half, Schaffner said.
"We're really quite convinced that they are keeping people with risk factors for serious disease out of the hospital," he said.
The key to getting monoclonals to work is to get them fast.
"Time is of the essence," said Dr. Howard Huang, medical director of the lung transplant program at Houston Methodist Hospital in Texas. "If you're combating a virus and trying to inhibit its multiplication, we're talking about every hour, every day you wait that makes a big, big difference."
Methodist set up a system to have pharmacists call people right after their diagnosis to encourage and educate them about the drugs' potential benefits.
Monoclonal antibodies are expected to be useful even as more people are vaccinated, Huang said. Those who are immunocompromised, such as his lung transplant patients, are unlikely to get full protection from vaccines and are at high risk for bad outcomes if they catch COVID-19. There also will be people who decline vaccination, then get sick.
Dr. Howard Huang, Houston Methodist Hospital
It's not something that's only available to rich and influential people. As a society we need to make sure everybody has equal access to that, especially the underserved population.
Getting an infusion early in their infection could be lifesaving, he said.
Huang and his colleagues have treated nearly 4,000 patients with monoclonal antibodies, most during Houston's COVID-19 surge in January. They contribute data to a national consortium that plans to aggregate information to identify who benefited the most from monoclonal antibodies.
Because the drugs, which would normally cost $2,000-$2,500 for a single-dose treatment, are provided for free and widely distributed, monoclonal antibodies should be made rapidly available to anyone at high risk, regardless of their ability to pay, Huang said.
"It's not something that's only available to rich and influential people," he said. "As a society, we need to make sure everybody has equal access to that, especially the underserved population."
But access remains a problem for many, he said.
The business of monoclonals
Two companies, Lilly and Regeneron, have monoclonals on the market. Regeneron started with its two-drug cocktail, REGEN-COV, and Lilly added a second monoclonal to its original drug, bamlanivimab, to provide more protection against coronavirus variants. Friday, the company announced it would no longer provide bamlanivimab alone.
Although experts warned the variants might make monoclonals less effective, the cocktails have kept that from happening, said Regeneron spokesperson Alexandra Bowie.
"REGEN-COV remains potent against the variants first identified in Brazil, South Africa, New York, California and the U.K.," she said via email.
The company has delivered about 300,000 doses of REGEN-COV under its initial contract with the U.S. government and is making supply for the second agreement, which will provide at least 750,000 more, Bowie said.
Dr. Amanda Peppercorn, vice president clinical development at GlaxoSmithKline
The pandemic has shown that monoclonal antibodies are a very rapid solution because of their predictable safety and dosage prediction – you can really model out how they're going to work.
The authors of federal guidelines for use of monoclonals expressed some concern about Lilly's combination proving less effective against many of the viral variants, though it appears to remain effective against the B.1.1.7 variant first seen in Britain.
GlaxoSmithKline, in collaboration with Vir Biotechnology, submitted a request to the FDA on March 26 for a monoclonal antibody of their own. They hope to receive authorization soon to provide a one-time, two-shot treatment, said Dr. Amanda Peppercorn, vice president of clinical development at GlaxoSmithKline.
The companies believe their antibody will work on its own, regardless of the variants, she said, but are studying it in combination with Lilly's bamlanivimab in case that proves more effective.
"The pandemic has shown that monoclonal antibodies are a very rapid solution because of their predictable safety and dosage prediction – you can really model out how they're going to work," Peppercorn said. "Because they're part of the human immune system, they're a very safe type of approach for a pandemic."
Monoclonal antibodies are similar in theory to convalescent plasma, in which patients are given a blood product from people who have recovered from the disease. Unfortunately, people infected with COVID-19 seem to make vastly different levels of antibodies, Peppercorn said, so although some doses of convalescent plasma may be useful, it has not proved effective overall.
By contrast, monoclonal antibodies, which originate in recovered patients, are selected for potency, she said, and they deliver a consistent dose.
GSK and the other companies are testing monoclonal antibodies as a prophylactic therapy, to prevent infections in people who have been exposed to the virus and are at high risk for severe disease.
Monoclonals provide protection for about three months.
Adagio, a biotechnology company based in Massachusetts, is developing a monoclonal it hopes will protect people for at least six months and launched clinical trials this week.
Its drug uses a different target on the coronavirus that causes COVID-19, which Adagio expects will be useful against variants as well as other coronaviruses, said company CEO and co-founder Tillman Gerngross. Its antibody, called ADG20, is more potent and could be administered via a single shot, rather than an infusion or a multiple-shot regimen, he said.
The company expects to submit a request for authorization to the FDA late this year.
Guadalupe Ramirez remains a big fan of monoclonal antibodies. She wants everyone at risk for severe COVID-19 to learn about and get them.
"Whatever is in this medication has kept people going. I don't know what it does, but you're good," she said. "The thing is to try it right away."
My FEMALE prayer: Before I lay me down to sleep, I pray for a man that's not a creep. One who is handsome, smart and strong. One who loves to listen long. One who thinks before he speaks. One who'll call and not wait for weeks. I pray he will be gainfully employed. When I spend his cash won't be annoyed. Pulls out my chair and opens my door. Massages my back and begs to do more...Oh! Send me a man who'll make love to my mind. Knows what to answer when I ask "How big is my behind". I pray that this man will love me to no end and always be my very best friend. Amen
Back in my med school days, I had to pull my fair share of all-nighters.
Sometimes, I'd even be up long enough to see the sunrise and hear the birds chirping!
(Hey — it was always worth it when I aced an exam the next day.)
Of course, when you're in your 20s… skipping a few hours of sleep is no big deal for your body.
However, when you turn 40, that all changes.
Because your body's ability to "make up" for lost sleep starts to fade. And research shows…
Not sleeping at night can be downright dangerous to your health.
This was proven in a recent study, published in the medical journal Diabetes Care.
Researchers studied a massive sample of 270,000 people who worked night shifts.
And they discovered that people who stayed up late — even just a handful of times — had a higher risk of developing Type 2 diabetes.
Not only that… these "night owls" burned SIGNIFICANTLY fewer calories than those who stuck to a normal sleep schedule.1
What's that mean?
Well, people who stay up late are more likely to pack on pounds and feel tired all the time.
After all, it makes sense — our bodies aren't designed to stay up too long past dark… so when you do, it puts your health under A LOT of stress.
However, there's good news…
Burning the midnight oil doesn't mean you have to feel wiped the next day…
It turns out there's a simple way to hack your sleep cycle… no matter when you decide to hit the sack.
All you have to do is…
Dunk your face into ice cold water.
Yep — sounds crazy, but it works!
(In fact, the researcher who discovered this phenomenon called it "The Master Switch of Life." That's how powerful a technique it is.)
Doing this before you go to bed — no matter what time it is — helps you fall asleep almost instantly.
(I almost didn't believe it myself, until I tried it for the first time… now it's something I do every night.)
Here's how it works…
When you immerse your face in cold water, it slows down your heart rate2…
And that puts you in the fast lane for getting a GREAT night's sleep…
… which means you'll waste no time "tossing and turning" or counting sheep.
Pretty cool, right?
So try this "Dunk Method" tonight. You'll be amazed by how quickly you drift off into dreamland.
Looking out for you,
Steven Gundry, MD
P.S. Not only will the "Dunk Method" help you go to sleep faster and wake up feeling refreshed… it's also EXCELLENT for your skin! You see, the cold water helps increase circulation to your facial pores — so you can enjoy a youthful, glowing complexion. Just another reason to give this neat hack a try. And after you do, remember to hit REPLY and let me know how it works for you. I love reading your emails, so don't be shy! :)
'Breakthrough' COVID-19 Cases, Deaths In CT: Here's What To Know
The COVID-19 vaccine is your best bet to avoid catching COVID-19, but it's not a total silver bullet.
So-called "vaccine breakthrough cases" occur when a person who has completed their vaccine series, is exposed to SARS-CoV-2 and then becomes infected with COVID-19. (Shutterstock)
CONNECTICUT — Of the 2,124,106 Connecticut residents who have been completely vaccinated, 854 still went on to contract COVID-19, according to data from the state Department of Public Health released this week.
So-called "vaccine breakthrough cases" occur when a person who has completed their vaccine series, is exposed to SARS-CoV-2 and then becomes infected with COVID-19. Twenty-one, or 2.5 percent, COVID-19 related deaths have occurred among the state's 854 vaccine breakthrough cases.
Although the numbers may come as a shock to residents who perceived the vaccine as some kind of elixir of immunity, the data "clearly show that the COVID-19 vaccines are highly effective at fighting the virus," according to DPH spokesman Chris Boyle. Less than 0.1 percent of Connecticut's fully vaccinated persons reported to DPH as having contracted the virus.
Among the 854 vaccine breakthrough cases, 393 had reported symptoms of the disease and 150 have been hospitalized. Most hospitalizations have occurred among residents 55 years and older, Boyle told Patch.
Seventeen of the 21 COVID-19 associated deaths among the breakthrough cases were suffered by the oldest population, aged 75 and over. Two were in the age group 55-64, and two were 65-74 years of age. Nationally, the CDC has reported a total of 988 vaccine breakthrough deaths.
DPH also announced that of the 854 breakthrough cases, 513 (60.0%) cases were among women, and 77 (9.0%) cases occurred among persons living in congregate settings such as nursing homes or assisted living facilities.
Due to the continued low COVID-19 case counts and high vaccination rates among Connecticut's long-term care facilities, the DPH has announced it is transitioning the release of its reports on nursing home facilities to every other week. The next nursing home report will be issued on Thursday, July 22, 2021.
Assisted living facilities are no longer required to report COVID-19 case counts on a weekly basis to the Department of Public Health, and the agency will bring an end to releasing regular reports of COVID-19 cases in assisted living facilities.
As of Thursday, Connecticut residents who have received at least one dose by age group include 96 percent of those over the age of 65, 85 percent of those between 55-64, 74 percent of those between 45-54, 75 percent of those between 35-44, 62 percent of those between 25-34,59 percent of those between 18-24, 66 of those between 16-17, and 49 percent of those between 12-15.(poor kids)
The trajectory of full vaccinations for the youngest eligible age group, 12-15, took off like a rocket at the beginning of June, but now shows signs of levelling off. As of Wednesday, 40.5 percent of residents in that demographic have been fully vaccinated, and 49.2 percent had at least one jab.
As of Friday, Connecticut is behind only Vermont and Massachusetts in the percentage of its population fully vaccinated against the virus, according to the Centers for Disease Control and Prevention.
In Mansfield, less than a third of the residents have been fully vaccinated, and just about 35 percent have had their first dose. Canaan continues to lead all Connecticut municipalities in rolling out the vaccine to its residents, with 92.21 percent of its population fully vaccinated as of Thursday.
The number of coronavirus delta variant cases identified by genetic sequencing in the state is up 36 cases, to 87. Among the state's other variants of concern, the week's biggest mover is variant epsilon, up 1,359 cases. Alpha is up 14, and gamma, 7. Cases of the beta variant held steady at 40.
Of the variants of interest currently found in Connecticut, incidents of variants zeta, eta and kappa have all held steady at nine, 21 and two, respectively. Cases of the iota variant rose by eight, to 1,805.
Whole genome sequencing results were reported to the DPH for 103 vaccine breakthrough cases, and only one was the highly-transmissible delta variant. Among these persons the following variants were reported; 61 (59.2%) alpha, 13 (12.6%) iota, 8 (7.8%) gamma, 2 (1.9%) beta, 2 (1.9%) eta, 2 (1.9%) delta, 1 (1.0%) epsilon, and 14 (13.6%) were other variants.
Three more virus-related deaths were reported this past week, bringing the death toll for the pandemic to 8,282 in Connecticut.
Red returns to the "red zone" this week. Franklin has recorded a positive case rate of 26 per 100,000 population over the last 2-week reporting period.
Towns fall into the red zone when they report 15 or more cases per 100K over a 2-week average. The color codes correspond to guidance from the state Department of Public Health.
An additional 738 cases of the coronavirus have been confirmed in the state over the past week, bringing that total to 350,536. With 11,759 tests reported Thursday, the daily positivity rate going into the weekend is 1.28 percent, up from m 0.52 percent seven days ago.
Although the positivity rate is far from its heights last spring, or even the fall surge, it is on par with the mid-summer levels from last year.
The number of Connecticut residents hospitalized with COVID-19 is 38, up 12 beds over the past week.
Vitamin D does treat liver disease. Way back in December 2009, I wrote about how vitamin D had brought myself and one other family member's liver markers into the normal range. This included a problem with hepatitis—
Clotho is one of the three Greek fates that are responsible for the thread of life in Greek mythology. Clotho is known as the spinner of the thread while the others draw out and cut. In our understanding of physiology, we have named the gene responsible for reduced chronic disease—Klotho. The up regulation of klotho appears to significantly reduce chronic disease. A few to consider are cancer, diabetes, rheumatoid arthritis, and coronary artery disease. Have we stumbled unto the gene that is responsible for the fountain of youth?
Excerpt: "...the Covid-19 Delta variant is fictitious, dreamt up by maniacal people who feared losing their stranglehold on a compliant citizenry. As society came to terms with a virus no more lethal than the common flu, and citizens eschewed masking and raised legitimate questions about hazardous vaccinations, the World Health Organization contacted its agents within the CDC and international health agencies and urged them to take part in a program aimed at once again scaring the world into frightened compliance. "It was Biden’s CDC Director, Rochelle Walensky, who recommended an illusory solution; fabricating a highly transmissible and potentially more virulent strain to 'scare people into wearing masks and getting vaccinations,' " https://realrawnews.com/2021/07/trump-pledges-to-blow-lid-off-global-plandemic/ [show less]